BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Biotech Beach

  Genalyte Inc. To Launch Early Access Program For Maverick(TM) Next-generation Multiplexing Platform At Upcoming Immunology Conferences

  May 1, 2012

   · 

  2 min read
• Biotech Bay

  Amarantus BioSciences, Inc. to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012

  May 1, 2012

   · 

  3 min read
• Drug Development

  PRANA Biotechnology Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression

  May 1, 2012

   · 

  5 min read
• Business

  PDI, Inc. Director Frank J. Ryan to Retire from Board

  May 1, 2012

   · 

  1 min read
• Pharm Country

  Discovery Laboratories Release: Pharmacoeconomic Analysis Shows SURFAXIN(R) May Reduce Hospital Cost Associated with Reintubation in Premature Infants

  May 1, 2012

   · 

  6 min read
• Biotech Beach

  AVANIR Pharmaceuticals To Present at Three Conferences In May

  May 1, 2012

   · 

  1 min read
• Business

  AnaptysBio, Inc. Announces Antibody Discovery Partnership With Gilead Sciences, Inc.

  May 1, 2012

   · 

  1 min read
• Business

  Angeion Corporation Appoints Matthew S. Margolies as Executive Vice President - Global Sales

  May 1, 2012

   · 

  5 min read
• Pharm Country

  BioSpecifics Technologies Corporation to Host Conference Call to Report First Quarter 2012 Financial Results on May 8, 2012

  May 1, 2012

   · 

  2 min read
• Drug Development

  Varian Medical Systems Release: Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way

  May 1, 2012

   · 

  4 min read